Journal article
Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma
Haematologica, Vol.99(10), pp.e193-e196
2014
DOI: 10.3324/haematol.2014.108258
PMCID: PMC4181268
PMID: 25271315
Abstract
Advances in Hodgkin lymphoma (HL) treatment have dramatically improved prognosis, with 5-year relative survival now over 80% in the United States (US) and Europe. However, subsequent malignancies, often occurring as late adverse effects of treatment, are a leading cause of morbidity and mortality
Details
- Title: Subtitle
- Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma
- Creators
- Lindsay M MortonEthel S GilbertGraça M DoresRuth A KleinermanStephanie LamartSteven L SimonJoseph F FraumeniRochelle E CurtisMarilyn StovallSusan A SmithRita E WeathersFlora E van LeeuwenCharles F LynchPer HallHans H StormDavid C HodgsonHeikki JoensuuLeila VaalavirtaTom Børge JohannesenFrøydis LangmarkMichael AnderssonEric J HolowatyMagnus KaijserEero PukkalaSophie D FossaLois B TravisBerthe M Aleman
- Resource Type
- Journal article
- Publication Details
- Haematologica, Vol.99(10), pp.e193-e196
- DOI
- 10.3324/haematol.2014.108258
- PMID
- 25271315
- PMCID
- PMC4181268
- ISSN
- 0390-6078
- eISSN
- 1592-8721
- Language
- English
- Date published
- 2014
- Academic Unit
- Epidemiology
- Record Identifier
- 9983995043902771
Metrics
13 Record Views